dc.contributor.author | Ekmekci, H. | |
dc.contributor.author | Tugcu, Deniz | |
dc.contributor.author | Aydogan, G. | |
dc.contributor.author | Unuvar, A. | |
dc.contributor.author | Devecioglu, O. | |
dc.contributor.author | Ozturk, G. | |
dc.contributor.author | Ekmekci, O. B. | |
dc.contributor.author | Anak, S. | |
dc.contributor.author | Akcay, A. | |
dc.date.accessioned | 2021-03-05T16:41:22Z | |
dc.date.available | 2021-03-05T16:41:22Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Tugcu D., Devecioglu O., Unuvar A., Ekmekci H., Ekmekci O. B. , Anak S., Ozturk G., Akcay A., Aydogan G., "Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer", CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, cilt.22, ss.28-33, 2016 | |
dc.identifier.issn | 1076-0296 | |
dc.identifier.other | av_c1d97098-7b3c-490e-93c6-af36255d09e5 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/128664 | |
dc.identifier.uri | https://doi.org/10.1177/1076029614531450 | |
dc.description.abstract | Background: The plasminogen activator system controls intravascular fibrin deposition; besides, it also participates in a wide variety of physiologic and pathologic processes, including cancer. | |
dc.language.iso | eng | |
dc.subject | Hematoloji | |
dc.subject | Tıp | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | PERİFERAL VASKÜLER HASTALIĞI | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | HEMATOLOJİ | |
dc.title | Plasma Levels of Plasminogen Activator Inhibitor Type 1 and Vitronectin in Children With Cancer | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 22 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 28 | |
dc.identifier.endpage | 33 | |
dc.contributor.firstauthorID | 228373 | |